Zobrazeno 1 - 10
of 70
pro vyhledávání: '"Longgen Liu"'
Publikováno v:
Annals of Medicine, Vol 56, Iss 1 (2024)
AbstractBackground and Aim This study aims to validate the efficacy of the conventional non-invasive score in predicting significant fibrosis in metabolic-associated fatty liver disease (MAFLD) and to develop a non-invasive prediction model for MAFLD
Externí odkaz:
https://doaj.org/article/58ca83b76ea84009b4668b37a90c0b71
Autor:
Xiujun Zhang, Guocan Si, Huifen Lu, Wei Zhang, Shuqin Zheng, Zeyu Huang, Longgen Liu, Yuan Xue, Guojun Zheng
Publikováno v:
Virology Journal, Vol 19, Iss 1, Pp 1-8 (2022)
Abstract Background Omicron variant (B.1.1.529) is a dominant variant worldwide. However, the risk factors for Omicron variant clearance are yet unknown. The present study aimed to investigate the risk factors for early viral clearance of Omicron var
Externí odkaz:
https://doaj.org/article/d08c567c6d194f97987e5c7d5dff457a
Autor:
Liming Zheng, Zeyu Huang, Xiaoping Li, Meifang He, Xiaoqin Liu, Guojun Zheng, Xike Zhou, Longgen Liu
Publikováno v:
BMC Gastroenterology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Early hepatocellular carcinoma (HCC) detection with non-invasive biomarkers remains an unmet clinical need. We aimed to construct a predictive model based on the pre-diagnostic levels of serum markers to predict the early-stage on
Externí odkaz:
https://doaj.org/article/9a2b4e245a744ef28c8dd6705edf1d81
Autor:
Bing-Yuan Wang, Lai Wei, Rui Huang, Jian-Gao Fan, Jun-Ping Shi, Yi-Min Mao, Jing-Min Zhao, Lun Gen Lu, Bi-Hui Zhong, Zheng-Sheng Zou, You-Qing Xu, Yi-Nong Ye, Longgen Liu, Lian-Jie Lin, Huiying Rao
Publikováno v:
BMJ Open, Vol 13, Iss 6 (2023)
Objectives Non-alcoholic fatty liver disease (NAFLD) is becoming the leading cause of chronic liver disease worldwide. However, treatment of NAFLD is potentially influenced by psychological conditions. Using the simplified version of the University o
Externí odkaz:
https://doaj.org/article/6dd162e1ca3e4bc38b54ef127d8b9910
Autor:
Rui Huang, Li Zhu, Leyang Xue, Xuebing Yan, Jian Wang, Songping Huang, Biao Zhang, Tianmin Xu, Fang Ji, Chunyang Li, Fang Ming, Yun Zhao, Yang Li, Juan Cheng, Yinling Wang, Huaping Shao, Shuqin Hong, Kang Chen, Xiang-an Zhao, Dawen Sang, Lei Zou, Haiyan Zhao, Xinying Guan, Xiaobing Chen, Biyun Xu, Juan Xia, Yuxin Chen, Xiaomin Yan, Jie Wei, Jiacheng Liu, Longgen Liu, Chuanwu Zhu, Chao Wu
Publikováno v:
Virology Journal, Vol 18, Iss 1, Pp 1-8 (2021)
Abstract Background The clinical and virological course of patients with coronavirus disease 2019 (COVID-19) are lacking. We aimed to describe the clinical and virological characteristics of COVID-19 patients from 10 designated hospitals in 10 cities
Externí odkaz:
https://doaj.org/article/3e92614b88734b3da361176fb12e06a4
Autor:
Yan Huang, Lichang Chen, Rui Huang, Chuanwu Zhu, Jia Shang, Yunsong Qian, Jianqi Lian, Longgen Liu, Jianning Jiang, Chenghai Liu, Honglian Gui, Qing Xie
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: Both tenofovir disoproxil fumarate (TDF) and entecavir (ETV) are known to reduce the risk of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). This study aimed to compare the difference in HCC risk reduction betwe
Externí odkaz:
https://doaj.org/article/822ce0af3f58419b967b3fc6af990475
Autor:
Xiaomei Wang, Xiumei Chi, Ruihong Wu, Hongqin Xu, Xiuzhu Gao, Lei Yu, Longgen Liu, Mingxiang Zhang, Youwen Tan, Junqi Niu, Qinglong Jin
Publikováno v:
Virology Journal, Vol 18, Iss 1, Pp 1-10 (2021)
Abstract Background Serum hepatitis B virus RNA (HBV RNA) has been reported to be a surrogate marker of intrahepatic cccDNA during nucleos(t)ide analogs therapy. However, in HBeAg-positive patients treated with peg-interferon (peg-IFN), whether HBV R
Externí odkaz:
https://doaj.org/article/94a2492fc4404c83985588cafc646055
Autor:
Xiaomei Wang, Zhongfeng Wang, Xiumei Chi, Ruihong Wu, Qinglong Jin, Hongqin Xu, Xiuzhu Gao, Lei Yu, Yuping Chen, Jia Shang, Longgen Liu, Shuqin Zhang, Yongfang Jiang, Mingxiang Zhang, Qiaoxia Tong, Lunli Zhang, Youwen Tan, Anlin Ma, Shuangsuo Dang, Bin Xu, Zhenjing Jin, Jia Li, Xiaobo Li, Fengmin Lu, Junqi Niu
Publikováno v:
International Journal of Infectious Diseases, Vol 99, Iss , Pp 171-178 (2020)
Background: In some previous studies, serum hepatitis B virus RNA (HBV RNA) was proposed as an HBV viral marker during therapy. However, the dynamic change of HBV RNA, the correlation of HBV RNA with cccDNA, and the combination of HBV RNA with known
Externí odkaz:
https://doaj.org/article/6beee7c6f6f74cc3adb76225e6b81d80
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2022 (2022)
Background. The aim of this study was to provide new insights into the prevalence of positive antinuclear antibody (ANA) in patients with HBV-related acute-on-chronic liver failure (ACLF) and its impact on clinical outcomes. Methods. A total of 116 p
Externí odkaz:
https://doaj.org/article/b8455697660b4921a1439c0e701de189
Publikováno v:
PeerJ, Vol 9, p e12554 (2021)
Background Early recurrence of hepatocellular carcinoma (HCC) is a major obstacle to improving the prognosis, and no widely accepted adjuvant therapy guideline for patients post-liver resection is available. Currently, all available methods and bioma
Externí odkaz:
https://doaj.org/article/3e08f6c374c74528b081541cbed5fc68